Axon Enterprise Inc vs Nike Inc — how do they compare? Axon Enterprise Inc trades at $550 (market cap $44.11B), while Nike Inc trades at $43.29 (market cap $63.47B). The key difference: Nike Inc is the larger of the two by market cap, and Nike Inc pays a 3.83% dividend while Axon Enterprise Inc pays none. Which is the better fit depends on your goals.
| AXON | NKE | |
|---|---|---|
Market Cap | $44.11B | $63.47B |
Sector | Technology | Consumer Cyclical |
52-Week High | $870.97 | $79.24 |
52-Week Low | $345.94 | $40.75 |
Enterprise Value | $45.20B | $65.48B |
Volume | — | 8,887,180 |
Dividend Yield | — | 3.83% |
Signals from Pluang's Aura AI — not financial advice
Axon Enterprise (AXON) trades at $547.03, down 3.32% on the day, with strong analyst support (81% buy ratings) and a consensus price target of $648.67. The stock shows bullish technical signals with support at $539 and resistance at $553. Recent earnings have been mixed with Q3 2025 missing estimates but Q4 2025 and Q1 2026 beating expectations. Revenue growth remains solid with 2026 projections at $3.0B and net profit margin improving to 6.9%.
Axon presents growth potential driven by strong demand for connected devices and software services, though elevated valuation ratios (P/E 220.67) pose risk. Positive sentiment stems from recent upgrades and institutional interest, including notable insider buying. Key risks include execution challenges and competitive pressures in the law enforcement technology sector.
Nike (NKE) trades at $43.76, down 1.37% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported revenue of $46.31B for 2025 with a net income margin of 6.7%, though earnings have beaten expectations in recent quarters. Analysts maintain a consensus buy rating with a $50.80 price target, suggesting potential upside from current levels.
Nike's outlook is supported by strong brand equity and consistent earnings beats, but faces headwinds from softer demand in China and margin pressure. The stock presents a value opportunity with a P/E of 20.41 below historical averages, though execution risks in the turnaround strategy remain key for investor confidence.
Trailing returns across standard periods
Latest headlines on both assets
Axon develops technology and weapons for law enforcement and military use. Its ecosystem includes TASER devices, body cameras, and Evidence.com, a cloud-based platform for digital evidence management.
Read more on AXON →NIKE, Inc. designs, develops, and markets athletic footwear, apparel, equipment, and accessory products for men, women, and children. The Company sells its products worldwide to retail stores, through its own stores, subsidiaries, and distributors.
Read more on NKE →